You have 9 free searches left this month | for more free features.

City

Bethesda (1)

Stockholm (1)

Condition

Growth Failure (2)

Chronic Liver Disease (1)

Growth Hormone Resistence (1)

Short Stature (1)

Type 1 Diabetes Mellitus (1)

X-linked Severe Combined Immunodeficiency (XSCID) (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

n/a (2)

phase 1/phase 2 (2)

Sponsor

Children's Hospital Medical Center, Cincinnati (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Peter Bang (1)

University of California, Los Angeles (1)

Collaborator

Intervention

increlex (4)

0.9% saline (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (4)

increlex

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Short Stature Trial (Increlex)

Active, not recruiting

Short Stature

Increlex

(no location specified)

Oct 14, 2022

Growth Failure, Chronic Liver Disease Trial (Increlex)

Withdrawn

Growth Failure
Chronic Liver Disease

Increlex

(no location specified)

Jul 12, 2016

Growth Failure, X-linked Severe Combined Immunodeficiency (XSCID), Growth Hormone Resistence Trial run by the NIAID (Increlex)

Terminated

Growth Failure
+2 more

Increlex

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jul 2, 2015

Type 1 Diabetes Trial in Stockholm (Increlex, 0.9% Saline)

Completed

Type 1 Diabetes Mellitus

Increlex
0.9% Saline

Stockholm, Sweden

Pediatric Endocrinology Unit, Dept of Women's and Children's Hea

Apr 27, 2012